Skip to main content

Study of Feasibility and Acceptability of Subcutaneous Implantable Ports (SIPs) in Cancer Patients

Abstract

Objective

To assess the feasibility and complication rate associated with Subcutaneous Implantable Ports (SIPs) in pediatric cancer patients.

Methods

Ninety nine patients underwent chemo port insertion between January2003 to May 2011 with variety of neoplastic diseases. Data was collected with regards to underlying condition, duration the catheter was in situ and complications during insertion, accessing and removal. Chemoport was inserted either at diagnosis or once optimal conditions were achieved. Ports were placed in internal jugular vein (IJV) or subclavian vein (SCV) under general or local anesthesia under strict aseptic conditions in theatre.

Results

A total of 100 ports were placed in 99 patients. The mean duration of the implantable ports was 393 days (range 30–1300). In 49 cases (49%), ports were removed electively, 15 cases (15%) died with port in situ and 36 cases (36%) still have port in situ and receiving chemotherapy without any complications. Complications observed were suspected infection (4%), port fracture (4%), thrombosis of catheter (1%) and blockage (1%).

Conclusions

The use of ports is safe and feasible in Pediatric Oncology patients if strict asepsis guidelines are followed.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Belin RP, Koster JK Jr, Bryant LJ, Griffen Wo Jr. Implantable subcutaneous feeding chamber for non contineous central venous alimentation. Surg Gynecol Obstet. 1972;134:491–3.

    Google Scholar 

  2. Mirro J Jr, Rao BN, Stockes DC. A prospective study of Hickman/Broviac catheters and implantable ports in pediatric oncology patients. J Clin Oncol. 1998;7:214–22.

    Google Scholar 

  3. Rouzrokh M, Shamsian BS, Tabari AKN, et al. Totally implantable subpectoral vs. subcutaneous port systems in children with malignant diseases. Arch Iranian Med. 2009;12:389–94.

    Google Scholar 

  4. Fortner JG, Pahnke LD. A new method for long term intrahepatic chemotherapy. Surg Gynecol Obstet. 1976;143:979–80.

    PubMed  CAS  Google Scholar 

  5. Niederhuber JE, Ensminger W, Gyves JW. Totally implantedvenous and arterial access system to replace external catheteres in cancer treatment. Surgery. 1982;92:706–11.

    PubMed  CAS  Google Scholar 

  6. Bucki B, Tomaszewska R, Bubala H, et al. Application of long term subcutaneously implanted access into the central veins system of "PORT" type in the Clinic of Pediatry, Pediatric Hematology and Oncology in Zabrze--15 year own observations. Wiad lek. 2009;62:93–8.

    PubMed  Google Scholar 

  7. Nam SH, Yeonkim D, Kim SC, et al. Complications and risk factors of infection in pediatric hemato-oncology patients with totally implantable access ports. Pediatr Blood Cancer. 2010;54:546–51.

    Google Scholar 

  8. Singh T, Satheesh C, Ankit J, et al. Use of Port-A-Cath in pediatric cancer patients: Experience from a tertiary cancer center in south India. J Clin Oncol. 2009;27:e20747.

    Google Scholar 

Download references

Conflict of Interest

None.

Role of Funding Source

None.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Lalit Mittal.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Mittal, L., Kalra, M. & Mahajan, A. Study of Feasibility and Acceptability of Subcutaneous Implantable Ports (SIPs) in Cancer Patients. Indian J Pediatr 79, 1601–1604 (2012). https://doi.org/10.1007/s12098-012-0711-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-012-0711-2

Keywords

  • Subcutaneous implantable ports
  • Chemo port
  • Cancer